Mexico looks to US on cannabis taxes • Epidiolex sales boom • NJ Gov talks cannabis in State of the State • & more…

An excerpt from recent editions of the Cannabis Wire Daily newsletter.

CBD, Regulation

FDA Approves Epidiolex for New Condition That Causes Benign Tumors, Seizures

Epidiolex contains cannabidiol, or CBD, extracted from cannabis plants, and was first approved to treat severe forms of epilepsy.


Epidiolex sales hit $188M • FreshDirect founder joins TerrAscend board • & more…

An excerpt from the November 5 and 6 editions of the Cannabis Wire Daily newsletter.

CBD, Congress

Congress Picks Up the Baton from the FDA on CBD, Seeking Data

The unregulated hemp-derived cannabinoid marketplace has exploded since the 2018 Farm Bill descheduled hemp. The FDA has asked Congress to help with a “new regulatory pathway.”


As FDA Looks to Congress for CBD Regs, it Elaborates on Potential Paths Forward 

On Thursday, the FDA pushed its desire to work with Congress on cannabinoid product rules, including delta-8 THC.


CBD’s Potential for Reproductive Harms Among “Big Reasons” Behind FDA’s Punt on Rules

The FDA is seeking a “harm reduction framework” as it works with Congress on a path for CBD, according to the agency’s Cannabis Product Committee lead.


Delaware becomes 22nd state to legalize cannabis for adult use • Clinical trial to examine CBD and social anxiety • & more …

An excerpt from a recent edition of the Cannabis Wire Daily newsletter.